Ubiquitin-mediated regulation of the RAD51D homologous recombination protein
泛素介导的 RAD51D 同源重组蛋白调节
基本信息
- 批准号:8689271
- 负责人:
- 金额:$ 32.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-09-01 至 2018-08-31
- 项目状态:已结题
- 来源:
- 关键词:Alternative SplicingAmino AcidsAntineoplastic AgentsBRCA1 geneBRCA2 geneBiologyBiomedical ResearchCancer-Predisposing GeneCarcinogenesis MechanismCellular biologyChromosomal StabilityClinicCo-ImmunoprecipitationsComplexConfocal MicroscopyCongenital AbnormalityDNADNA DamageDNA Interstrand CrosslinkingDataDefectDevelopmentDoctor of PharmacyDouble Strand Break RepairDrug TargetingEnzymesExposure toFamily memberFellowshipGenesGeneticGenomeGenomic InstabilityHuman GenomeIndividualInfertilityInstitutionLaboratoriesLysineMalignant NeoplasmsMalignant neoplasm of ovaryMass Spectrum AnalysisMediatingMinorityMutationNew YorkPathway interactionsPharmacologic SubstancePharmacy StudentsPhenotypePost-Translational Protein ProcessingPremature aging syndromeProcessProgram ReviewsProtein IsoformsProteinsRad51 recombinaseRecruitment ActivityRegulationResearchResearch TrainingScienceScientistSiteSouth CarolinaTechniquesTestingTexasTrainingUbiquitinUbiquitinationUnderrepresented MinorityUniversitiesYeastscancer cellchemotherapycollegedemographicsenvironmental agentexperiencegraduate studenthigh schoolhomologous recombinationmembermulticatalytic endopeptidase complexmutantnovelprogramsprotein functionpublic health relevancerepairedresearch studyresponseteachertoolubiquitin-protein ligaseundergraduate studentyeast two hybrid system
项目摘要
PROJECT SUMMARY
Mutations in RAD51 genes confer genome instability phenotypes associated with infertility, birth defects, and
cancer. Each of the RAD51 family members are central components of the error-free double strand break
(DSB) repair pathway known as homologous recombination (HR), and RAD51D was recently identified as an
ovarian cancer susceptibility gene. Even though it is known that HR defects predispose individuals to
malignancy and confers cancer cell sensitivity to DNA damaging chemotherapy agents, single-protein analyses
have revealed little functional information. Therefore, we performed RAD51D protein interaction screens and
identified RNF138, a novel RING domain E3 ubiquitin ligase enzyme. Ubiquitin is a 76-amino acid protein that
modifies protein functions or marks them for proteasome degradation, leading to the central hypothesis of this
application: RAD51D forms adaptive complexes that are tightly regulated by RNF138 to process DNA breaks
and maintain genome integrity. To test this hypothesis, the first aim will determine how RNF138 and RAD51D
interaction regulates the HR DNA damage response pathway. The second aim will identify the ubiquitin linkage
arrangements and sites along the RAD51D protein and their association with DNA damage response. Over the
course of this project, undergraduate, graduate, and Doctor of Pharmacy students will receive outstanding
biomedical research training. Undergraduate students are recruited from the highly selective University of
South Carolina Honors College, which is ranked first by the Public University Honors Program "Review of Fifty
Public University Honors Programs." Therefore, investigating RAD51D post-translational modifications will
uncover mechanisms of carcinogenesis pathways and identify potential cancer drug targets as well as provide
training in state-of-the-art biomedical science techniques.
项目摘要
RAD51基因的突变赋予基因组不稳定性表型与不育症,先天缺陷和
癌症。每个RAD51家庭成员都是无错误的双链断裂的中心组成部分
(DSB)修复途径称为同源重组(HR),而RAD51D最近被确定为
卵巢癌敏感性基因。即使知道人力资源缺陷使人倾向于
恶性肿瘤并赋予癌细胞对DNA损害化疗剂的敏感性,单蛋白分析
揭示了几乎没有功能信息。因此,我们进行了RAD51D蛋白相互作用筛选和
鉴定出RNF138,这是一种新型的环域E3泛素连接酶。泛素是一种76-氨基酸蛋白
修饰蛋白质功能或标记它们以降解蛋白酶体,从而导致中心假设
应用:RAD51D形成由RNF138严格调节以处理DNA断裂的自适应复合物
并保持基因组完整性。为了检验这一假设,第一个目标将决定RNF138和RAD51D如何
相互作用调节HR DNA损伤响应途径。第二个目标将确定泛素连接
沿RAD51D蛋白的排列和位点及其与DNA损伤反应的关联。在
这个项目的课程,本科,研究生和药房的学生将获得出色的
生物医学研究培训。本科生是从高度选择性大学招募的
南卡罗来纳州荣誉学院,该学院由公立大学荣誉计划排名第一。
公立大学荣誉计划。”因此,调查RAD51D翻译后修改将
发现癌变途径的机制,并确定潜在的癌症药物靶标,并提供
在最先进的生物医学科学技术中培训。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Homologous Recombination-Mediated DNA Repair and Implications for Clinical Treatment of Repair Defective Cancers.
- DOI:10.1007/978-1-4939-9500-4_1
- 发表时间:2019
- 期刊:
- 影响因子:0
- 作者:N. M. Reilly;B. Yard;D. Pittman
- 通讯作者:N. M. Reilly;B. Yard;D. Pittman
RNF138 interacts with RAD51D and is required for DNA interstrand crosslink repair and maintaining chromosome integrity.
- DOI:10.1016/j.dnarep.2016.04.006
- 发表时间:2016-06
- 期刊:
- 影响因子:3.8
- 作者:Yard BD;Reilly NM;Bedenbaugh MK;Pittman DL
- 通讯作者:Pittman DL
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DOUGLAS Lee PITTMAN其他文献
DOUGLAS Lee PITTMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DOUGLAS Lee PITTMAN', 18)}}的其他基金
相似国自然基金
胃肠道微生物宏基因组的氨基酸消旋酶挖掘及分析
- 批准号:32360034
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
甘油制α-氨基酸钌基双金属催化剂的构筑及产物调控策略
- 批准号:22308255
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
射频协同纳他霉素干扰氨基酸转运高效杀灭黑曲霉的分子机制研究
- 批准号:32302279
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
αKG-NHFe酶FtmOx1通过氨基酸多重构象变化催化内过氧化反应的机理研究
- 批准号:22307037
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
18F-TZA分子探针靶向识别胶质瘤IDH1突变及其与氨基酸转运体的关联研究
- 批准号:82302337
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Novel Topoisomerase II alpha isoform as a drug resistance determinant
新型拓扑异构酶 II α 亚型作为耐药决定因素
- 批准号:
10297850 - 财政年份:2018
- 资助金额:
$ 32.53万 - 项目类别:
Novel Topoisomerase II alpha isoform as a drug resistance determinant
新型拓扑异构酶 II α 亚型作为耐药决定因素
- 批准号:
10057231 - 财政年份:2018
- 资助金额:
$ 32.53万 - 项目类别:
Novel Topoisomerase II alpha isoform as a drug resistance determinant
新型拓扑异构酶 II α 亚型作为耐药决定因素
- 批准号:
10531227 - 财政年份:2018
- 资助金额:
$ 32.53万 - 项目类别:
Integrated high throughput proteogenomic data analysis center for CPTAC
CPTAC 集成高通量蛋白质组数据分析中心
- 批准号:
10004584 - 财政年份:2016
- 资助金额:
$ 32.53万 - 项目类别:
Integrated high throughput proteogenomic data analysis center for CPTAC
CPTAC 集成高通量蛋白质组数据分析中心
- 批准号:
9763516 - 财政年份:2016
- 资助金额:
$ 32.53万 - 项目类别: